Literature DB >> 33800736

The Importance of Drosophila melanogaster Research to UnCover Cellular Pathways Underlying Parkinson's Disease.

Melissa Vos1, Christine Klein1.   

Abstract

Parkinson's disease (PD) is a complex neurodegenerative disorder that is currently incurable. As a consequence of an incomplete understanding of the etiology of the disease, therapeutic strategies mainly focus on symptomatic treatment. Even though the majority of PD cases remain idiopathic (~90%), several genes have been identified to be causative for PD, facilitating the generation of animal models that are a good alternative to study disease pathways and to increase our understanding of the underlying mechanisms of PD. Drosophila melanogaster has proven to be an excellent model in these studies. In this review, we will discuss the different PD models in flies and key findings identified in flies in different affected pathways in PD. Several molecular changes have been identified, of which mitochondrial dysfunction and a defective endo-lysosomal pathway emerge to be the most relevant for PD pathogenesis. Studies in flies have significantly contributed to our knowledge of how disease genes affect and interact in these pathways enabling a better understanding of the disease etiology and providing possible therapeutic targets for the treatment of PD, some of which have already resulted in clinical trials.

Entities:  

Keywords:  Drosophila melanogaster; Parkinson’s disease; endo-lysosomal pathway; lipid homeostasis; mitochondria

Year:  2021        PMID: 33800736      PMCID: PMC7998316          DOI: 10.3390/cells10030579

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  201 in total

1.  Rab7 induces clearance of α-synuclein aggregates.

Authors:  Elisabeth Dinter; Theodora Saridaki; Markus Nippold; Sarah Plum; Leonie Diederichs; Daniel Komnig; Luisa Fensky; Caroline May; Katrin Marcus; Aaron Voigt; Jörg B Schulz; Björn H Falkenburger
Journal:  J Neurochem       Date:  2016-08-04       Impact factor: 5.372

2.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

3.  alpha-Synuclein is phosphorylated in synucleinopathy lesions.

Authors:  Hideo Fujiwara; Masato Hasegawa; Naoshi Dohmae; Akiko Kawashima; Eliezer Masliah; Matthew S Goldberg; Jie Shen; Koji Takio; Takeshi Iwatsubo
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

Review 4.  Neuronal vulnerability, pathogenesis, and Parkinson's disease.

Authors:  David Sulzer; D James Surmeier
Journal:  Mov Disord       Date:  2013-04-15       Impact factor: 10.338

5.  The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator.

Authors:  N Webster; J R Jin; S Green; M Hollis; P Chambon
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

6.  Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.

Authors:  Latha Devi; Vijayendran Raghavendran; Badanavalu M Prabhu; Narayan G Avadhani; Hindupur K Anandatheerthavarada
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

7.  The yeast complex I equivalent NADH dehydrogenase rescues pink1 mutants.

Authors:  Sven Vilain; Giovanni Esposito; Dominik Haddad; Onno Schaap; Mariya P Dobreva; Melissa Vos; Stefanie Van Meensel; Vanessa A Morais; Bart De Strooper; Patrik Verstreken
Journal:  PLoS Genet       Date:  2012-01-05       Impact factor: 5.917

8.  An omics-based strategy using coenzyme Q10 in patients with Parkinson's disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial.

Authors:  Jannik Prasuhn; Norbert Brüggemann; Nicole Hessler; Daniela Berg; Thomas Gasser; Kathrin Brockmann; Denise Olbrich; Andreas Ziegler; Inke R König; Christine Klein; Meike Kasten
Journal:  Neurol Res Pract       Date:  2019-08-23

9.  VPS35 pathogenic mutations confer no dominant toxicity but partial loss of function in Drosophila and genetically interact with parkin.

Authors:  Bilal R Malik; Vinay K Godena; Alexander J Whitworth
Journal:  Hum Mol Genet       Date:  2015-08-06       Impact factor: 6.150

10.  Unfolded protein response in Gaucher disease: from human to Drosophila.

Authors:  Gali Maor; Sigal Rencus-Lazar; Mirella Filocamo; Hermann Steller; Daniel Segal; Mia Horowitz
Journal:  Orphanet J Rare Dis       Date:  2013-09-11       Impact factor: 4.123

View more
  7 in total

1.  Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson's Disease.

Authors:  Brady T Mannett; Braden C Capt; Krista Pearman; Lori M Buhlman; John M VandenBrooks; Gerald B Call
Journal:  Parkinsons Dis       Date:  2022-07-08

Review 2.  'Fly-ing' from rare to common neurodegenerative disease mechanisms.

Authors:  Mengqi Ma; Matthew J Moulton; Shenzhao Lu; Hugo J Bellen
Journal:  Trends Genet       Date:  2022-04-25       Impact factor: 11.821

3.  Chronic Exposure to Paraquat Induces Alpha-Synuclein Pathogenic Modifications in Drosophila.

Authors:  Jean-Noël Arsac; Marianne Sedru; Mireille Dartiguelongue; Johann Vulin; Nathalie Davoust; Thierry Baron; Bertrand Mollereau
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 4.  Neurodegenerative Disorders: Spotlight on Sphingolipids.

Authors:  Frida Mandik; Melissa Vos
Journal:  Int J Mol Sci       Date:  2021-11-05       Impact factor: 5.923

5.  Mitochondrial Complex I deficiency: guilty in Parkinson's disease.

Authors:  Melissa Vos
Journal:  Signal Transduct Target Ther       Date:  2022-04-23

6.  Melatonin Increases Life Span, Restores the Locomotor Activity, and Reduces Lipid Peroxidation (LPO) in Transgenic Knockdown Parkin Drosophila melanogaster Exposed to Paraquat or Paraquat/Iron.

Authors:  Hector Flavio Ortega-Arellano; Marlene Jimenez-Del-Rio; Carlos Velez-Pardo
Journal:  Neurotox Res       Date:  2021-08-02       Impact factor: 3.911

7.  Phytochemicals of Avocado Residues as Potential Acetylcholinesterase Inhibitors, Antioxidants, and Neuroprotective Agents.

Authors:  Geisa Gabriela da Silva; Lúcia Pinheiro Santos Pimenta; Júlio Onésio Ferreira Melo; Henrique de Oliveira Prata Mendonça; Rodinei Augusti; Jacqueline Aparecida Takahashi
Journal:  Molecules       Date:  2022-03-15       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.